Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,876-1,900 of 2,022
CompletedNCT01354353

A Study of Safety and Tolerability in Subjects With Schizophrenia

This study exists to better understand the safety of the medication Safety and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Safety in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
CompletedNCT01452919

A Physical Dependence Study in Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Greece, United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
CompletedNCT03873337

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Rutgers, The State University of New Jersey
Condition
Schizophrenia
TerminatedNCT04140773

The Effect of D-serine as add-on Therapy in Recent-onset Psychosis

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Switzerland
Sponsor
Dragos Inta
Condition
Schizophrenia
TerminatedNCT01328093

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand how people respond to the medication LY2140023 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Austria, Belgium, France, Germany, Poland, United States, Romania, Spain, Sweden
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
CompletedNCT01052103

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Israel, Italy, Spain, United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
CompletedNCT02504151

Cannabidiol Treatment in Patients With Early Psychosis

This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT03652974

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
CompletedNCT03788759

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Condition
Schizophrenia
CompletedNCT03497013

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

This study exists to understand whether questionnaires and follow-up reports is both safe enough and useful enough to take further. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
China
Sponsor
Suzhou Psychiatric Hospital
Condition
Schizophrenia
CompletedNCT02686697

Carnosine and Cognitive Training in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Abraham Reichenberg
Condition
Schizophrenia
CompletedNCT02887794

Basic Auditory Processing and Auditory Hallucinations

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT02976077

RC2S+: Remediation of Social Cognitive Impairments

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03872310

Cognitive Enhancement on Working Memory in Patients With Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 55 Years
Countries
Taiwan
Sponsor
Taipei Medical University Shuang Ho Hospital
Condition
Schizophrenia
CompletedNCT02678858

Efficacy of ISST in Schizophrenia

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Heinrich-Heine University, Duesseldorf
Condition
Schizophrenia
TerminatedNCT03340909

The Norwegian Prednisolone in Early Psychosis Study

This study exists to understand how blood tests and biological markers holds up over time after the earliest research stage. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
Schizophrenia
CompletedNCT03985904

Museum-based Group Art Therapy in Mental Health Recovery

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Condition
Schizophrenia
CompletedNCT04024371

Validating Reward-related Biomarkers (RTOC)

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 20 Years to 55 Years
Countries
Germany, Greece, Netherlands, Spain
Sponsor
Maastricht University
Condition
Schizophrenia
CompletedNCT03576976

Improving Accessibility and Personalization of CR for Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
TerminatedNCT02739347

Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
Schizophrenia
SuspendedNCT02108899

Retrieval Practice and Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
CompletedNCT03007628

Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT01100775

Effects of Galantamine on Cognition

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research